DGX News and Press, Quest Diagnostics Incorporated From 01/26/24

2024-01-26 16:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma PR Newswire BALTIMOR...

2024-01-18 05:04:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Blood tests for dozens of types of cancer have been invented. These tests, known as liquid biopsies, could save tens of millions of lives. That’s because there’s currently no good...

2024-01-17 12:22:09 ET More on Quest Diagnostics Quest Diagnostics: Market Overreaction Creates Investment Opportunity Quest Diagnostics: Moving Past Covid Quest Diagnostics Inc. (DGX) Q3 2023 Earnings Call Transcript Quest, Ultima Genomics team up on MRD tes...

Quest Diagnostics to Release Fourth Quarter and Full Year 2023 Financial Results on February 1, 2024 PR Newswire SECAUCUS, N.J. , Jan. 17, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic information ser...

Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health PR Newswire Study to evaluate how behavioral and sensor data from wearables and blood tests can be leveraged to help individuals better assess and manage...

2024-01-16 11:49:56 ET More on iShares Russell 1000 Growth ETF: IWF: Price Isn't Everything; Favor Growth Over Value Citi’s 30 stocks for its 2024 top themes Top overweight stocks with high growth and low volume - MS Seeking Alpha’s Quant Rating...

2024-01-15 08:00:15 ET Quest Diagnostics, Inc. (DGX) declaring a stock dividend of $0.71 per share on Ex-Date : January 16, 2024. Shareholders on record as of January 17, 2024 are eligible for the dividend. The payment date is scheduled for January 31, 2024, and the declaration was ...

2024-01-09 09:41:19 ET More on Quest Diagnostics Quest Diagnostics: Market Overreaction Creates Investment Opportunity Quest Diagnostics: Moving Past Covid Quest Diagnostics Inc. (DGX) Q3 2023 Earnings Call Transcript BofA raises Quest to buy, calls it "growt...

Goal to combine Ultima’s highly sensitive, low-cost technology with Quest’s oncology expertise and national scale in order to improve patient access, affordability and outcomes Ultima Genomics , a developer of a revolutionary new ultra-high throughput sequencing archit...